Kira Scherer Wampler Sells 9,000 Shares of Doximity (NYSE:DOCS) Stock

Doximity, Inc. (NYSE:DOCS) Director Kira Scherer Wampler sold 9,000 shares of the business’s stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $26.06, for a total value of $234,540.00. Following the transaction, the director owned 19,839 shares of the company’s stock, valued at $517,004.34. This trade represents a 31.21% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Kira Scherer Wampler also recently made the following trade(s):

• On Tuesday, March 3rd, Kira Scherer Wampler sold 2,000 shares of Doximity stock. The stock was sold at an average price of $26.00, for a total value of $52,000.00.

Doximity Price Performance

Shares of DOCS stock opened at $25.97 on Friday. The business’s 50 day simple moving average is $24.22. Doximity, Inc. has a 52-week low of $20.55 and a 52-week high of $76.51. The company has a market cap of $4.80 billion, a price-to-earnings ratio of 21.65, a P/E/G ratio of 1.85 and a beta of 1.36.

Doximity (NYSE:DOCS) last released its earnings results on Thursday, February 5th. The company reported $0.46 earnings per share for the quarter, topping analysts’ consensus estimates of $0.45 by $0.01. Doximity had a return on equity of 23.84% and a net margin of 37.54%.The business’s revenue was up 9.8% on a year-over-year basis. During the same period last year, the business earned $0.45 EPS. On average, equities research analysts anticipate that Doximity, Inc. will post 1.11 earnings per share for the current fiscal year.

Doximity declared that its board has approved a stock buyback program on Thursday, February 5th that authorizes the company to repurchase $500.00 million in outstanding shares. This repurchase authorization authorizes the company to reacquire up to 8% of its shares through open market purchases. Shares repurchase programs are often a sign that the company’s board of directors believes its stock is undervalued.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the stock. Needham & Company LLC upgraded shares of Doximity to a “moderate buy” rating in a research note on Friday, February 6th. Freedom Capital raised shares of Doximity to a “strong-buy” rating in a research note on Tuesday, March 17th. Truist Financial reiterated a “hold” rating and issued a $29.00 price target (down from $37.00) on shares of Doximity in a report on Monday, April 20th. The Goldman Sachs Group dropped their price objective on Doximity from $34.00 to $28.00 and set a “neutral” rating on the stock in a research note on Thursday, April 9th. Finally, Barclays decreased their target price on Doximity from $63.00 to $38.00 and set an “overweight” rating for the company in a research report on Wednesday, February 11th. Two research analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating and eight have issued a Hold rating to the company’s stock. According to MarketBeat.com, Doximity presently has a consensus rating of “Moderate Buy” and an average target price of $41.26.

Hedge Funds Weigh In On Doximity

A number of large investors have recently bought and sold shares of the business. Vanguard Group Inc. raised its position in shares of Doximity by 4.1% in the 4th quarter. Vanguard Group Inc. now owns 13,285,485 shares of the company’s stock worth $588,281,000 after acquiring an additional 518,916 shares in the last quarter. SG Americas Securities LLC boosted its position in Doximity by 335.9% during the third quarter. SG Americas Securities LLC now owns 52,993 shares of the company’s stock valued at $3,876,000 after purchasing an additional 40,837 shares in the last quarter. Aubrey Capital Management Ltd bought a new stake in Doximity during the third quarter valued at about $4,572,000. Blair William & Co. IL grew its stake in Doximity by 1,990.7% in the third quarter. Blair William & Co. IL now owns 362,740 shares of the company’s stock valued at $26,534,000 after purchasing an additional 345,390 shares during the last quarter. Finally, William Blair Investment Management LLC grew its stake in Doximity by 11.7% in the third quarter. William Blair Investment Management LLC now owns 5,829,169 shares of the company’s stock valued at $426,404,000 after purchasing an additional 609,775 shares during the last quarter. Institutional investors own 87.19% of the company’s stock.

About Doximity

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.